A Retrospective Cohort Study of the Potency of lipid-lowering therapy and Race-gender Differences in LDL cholesterol control
<p>Abstract</p> <p>Background</p> <p>Reasons for race and gender differences in controlling elevated low density lipoprotein (LDL) cholesterol may be related to variations in prescribed lipid-lowering therapy. We examined the effect of lipid-lowering drug treatment and...
Main Authors: | Weiner Mark, Hollenbeak Christopher S, Turner Barbara J, Tang Simon SK |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-09-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2261/11/58 |
Similar Items
-
Use of Various Sugarcane Byproducts to Produce Lipid Extracts with Bioactive Properties: Physicochemical and Biological Characterization
by: Joana Odila Pereira, et al.
Published: (2024-02-01) -
Finger Millet Seed Coat—A Functional Nutrient-Rich Cereal By-Product
by: Oluwatoyin Oladayo Onipe, et al.
Published: (2022-11-01) -
LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse[S]
by: Elaine M. Quinet, et al.
Published: (2009-12-01) -
Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy
by: Zhang Rui, et al.
Published: (2012-05-01) -
The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function
by: Assunta Di Costanzo, et al.
Published: (2023-07-01)